Short answer
Epitalon (also written Epithalon) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. It has been studied since the 1990s in telomere biology, pineal gland research and longevity-related models. It is sold as a lyophilized research powder for laboratory use only.
Structure and origin
Epitalon is one of the shortest research peptides on the market - just four amino acids: alanine, glutamic acid, aspartic acid and glycine. It was designed by the Russian researcher V. Khavinson and colleagues, who studied short peptides derived from tissue extracts and their effects on cellular aging models. A 2002 review in Neuro Endocrinology Letters describes the framework behind the molecule: the peptide is modeled on a pineal extract (epithalamin) and is reported to reproduce its effects in experimental models [2].
A 2003 study in the Bulletin of Experimental Biology and Medicine reported that Epithalon induced telomerase activity and telomere elongation in human somatic cell cultures [1]. Telomeres are the protective caps at the ends of chromosomes, and telomerase is the enzyme that maintains them - which is why Epitalon appears in longevity research.
The choice of a four-amino-acid sequence is itself part of the research story. The peptide was derived from a larger pineal extract, and the researchers who designed it proposed that short fragments of tissue peptides retain biological activity while being simple to synthesize and characterize. The 2021 systematic review by Khavinson and colleagues formalizes this idea, describing how very short peptides can enter cell nuclei and interact with DNA and histones to regulate gene expression [3]. Epitalon is presented in that framework as the AEDG peptide, one of several minimal bioregulatory sequences studied by the group.
The telomere-telomerase mechanism
The most-cited line of Epitalon research concerns telomere biology. Telomeres shorten with each cell division, and when they become critically short, cells stop dividing and enter a state of replicative senescence. Telomerase is the enzyme that rebuilds telomeres, but most somatic cells express very little of it. The 2003 study reported that adding Epitalon to telomerase-negative human fetal fibroblast cultures induced expression of the telomerase catalytic subunit (hTERT), activated telomerase activity and elongated telomeres [1].
A 2004 follow-up extended this observation. Khavinson and colleagues reported that fibroblasts exposed to Epitalon reached roughly 44 passages compared with a limit of 34 passages in control cells, meaning the peptide extended the proliferative capacity of the cells beyond their normal division limit [4]. This is a measurable, cell-level outcome that connects the short peptide to a specific molecular pathway.
For researchers planning experiments around this mechanism, the key measurements are well defined. Telomere length can be measured directly, telomerase activity can be assayed enzymatically, and the expression of the catalytic subunit hTERT can be quantified at the RNA or protein level [1][4]. Because the reported pathway is gene-expression based rather than receptor-based, designs typically combine a molecular readout (hTERT expression, telomere length) with a functional readout (proliferative capacity), so the two can be checked against each other.
The bioregulatory peptide framework
Epitalon is one example of a broader research program in short regulatory peptides. A 2021 systematic review in Molecules, led by Khavinson, examines how short peptides of two to seven amino acids can enter cell nuclei and regulate gene expression through interactions with DNA and histone proteins, and it specifically discusses the AEDG peptide (Epitalon) [3]. The underlying idea is that very short peptides act as evolutionarily ancient signaling molecules that fine-tune gene expression rather than acting through conventional receptor pathways.
This framework matters for how a researcher interprets Epitalon data. The reported effects - telomerase activation, gene expression changes, pineal-related regulation - are framed as consequences of peptide-mediated regulation of gene transcription [3]. Because the molecule is so small, it does not fit the usual lock-and-key drug model, and much of the research is descriptive of what the peptide does in specific cell and animal systems.
The systematic-review framing also suggests a research direction worth noting. If very short peptides regulate gene expression by interacting with DNA and histones, then a natural experiment is to compare the AEDG sequence against closely related variants to ask which residues are essential for the reported activity. Comparative studies of this kind are common in peptide research and are a practical way to test whether the four-residue sequence is doing the work attributed to it, or whether the effects depend on something else in the preparation.
Research themes
The pineal research angle
Epitalon's other major research context is the pineal gland. The peptide is modeled on a pineal extract called epithalamin, and the 2002 review in Neuro Endocrinology Letters describes Epitalon as reproducing the effects of epithalamin in experimental models, including the restoration of circadian rhythms in aged animal models [2]. Because the pineal gland is the source of melatonin and a key regulator of circadian rhythms, this line of research connects the short peptide to questions about biological rhythms and age-related changes in those rhythms.
This is a different research tradition from the telomere work, and it is worth keeping the two separate when reading the literature. The telomere-telomerase studies are cellular and molecular, measuring hTERT expression and telomere length [1][4]. The pineal studies are more organismal, measuring melatonin-related outputs and behavioral rhythms in animal models [2]. Both fall under the broad "longevity-related models" umbrella, but they ask different questions and should be evaluated on their own evidence.
Reading the evidence critically
The Epitalon literature has characteristics that deserve a careful read. The primary work originates largely from a single research group, spans a limited number of model systems, and is often published in journals that may be less familiar to researchers outside the field. The telomere-telomerase findings are reported at the cell level [1][4], and the systematic review of short-peptide gene regulation provides a conceptual framework [3], but there is no large, independent, multi-center body of work on the molecule.
None of this invalidates the research, but it does mean a laboratory should regard Epitalon findings as preliminary and model-specific rather than as established effects. The same standard applies as with any research peptide: confirm identity and purity, design experiments with appropriate controls, and interpret results within the model that produced them.
How labs work with Epitalon
Because Epitalon is a small, water-soluble tetrapeptide, standard laboratory workflows apply: reconstitute the lyophilized powder with the solvent specified in the protocol, keep it cold and dark after reconstitution, and use batch-level quality data to confirm identity and purity. For handling details, see our peptide storage guide.
What to know before buying
| Check | Why it matters |
|---|---|
| Identity (MS) | Confirms the exact Ala-Glu-Asp-Gly sequence |
| Purity (HPLC) | 99%+ for reliable experiments |
| Batch COA | Traceable quality per batch |
| Lyophilized form | Better stability in shipping and storage |
| RUO label | Laboratory research use only |
Epitalon in context
Epitalon is often grouped with other short peptides and with molecules studied in the longevity research space. It differs from BPC-157 and TB-500, which are studied for tissue repair mechanisms, and from NAD+, a coenzyme studied for its role in cellular energy and enzyme activity. Epitalon's research niche is defined by its short peptide structure and its reported effects on telomere maintenance and pineal-related models. A researcher choosing between them would base the decision on the specific experimental question.
Storage and handling
Epitalon is supplied as a lyophilized powder and follows standard peptide storage practice:
Experimental considerations for short peptides
Working with a tetrapeptide like Epitalon has a few unique aspects. Because the molecule is so small, it is highly water soluble, which makes reconstitution straightforward, but it also means the material can be lost to adsorption on plastic surfaces in very dilute solutions - a consideration when preparing low-concentration stocks. The identity check is simple: the Ala-Glu-Asp-Gly sequence has a defined molecular mass, so mass spectrometry should confirm it unambiguously.
Because the reported effects depend on gene-expression regulation rather than a conventional receptor interaction [3], experimental designs often include gene-expression readouts - such as telomerase subunit expression or senescence markers - alongside functional measurements like telomere length or proliferative capacity [1][4]. Running both types of readout gives a study internal consistency: the molecular change should match the functional outcome.
FAQ
What is Epitalon?
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied since the 1990s.
What research has been done?
Published work includes telomerase activity in human cell cultures and pineal gland research models.
Is Epitalon for human use?
No, laboratory research use only.
What should I check when buying?
Batch COA, HPLC purity, MS identity and RUO labeling.
References
See Epitalon product options and the longevity research category for specifications.